Geode Capital Management, LLC
- SEC CIK
- 0001214717
- Latest filing
- Aug 12, 2026
RNAZ holding history
Transcode Therapeutics, Inc. in every 13F filed by Geode Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RNAZ overviewAll 13F holders of RNAZFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −12,740−100.0% | Sold out | Holders |
| Q1 2026 | 12,740 | $109.7K | <0.1% | +12,740 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −121,768−100.0% | Sold out | Holders |
| Q3 2024 | 121,768 | $69.5K | <0.1% | +83,370+217.1% | Added | Holders |
| Q2 2024 | 38,398 | $38.6K | <0.1% | +38,398 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −52,232−100.0% | Sold out | Holders |
| Q4 2023 | 52,232 | $8.61K | <0.1% | +52,232 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −75,683−100.0% | Sold out | Holders |
| Q1 2023 | 75,683 | $25.6K | <0.1% | −866−1.1% | Reduced | Holders |
| Q4 2022 | 76,549 | $51.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 76,549 | $84.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 76,549 | $96.0K | <0.1% | +5,277+7.4% | Added | Holders |
| Q1 2022 | 71,272 | $205.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 71,272 | $181.0K | <0.1% | +54,249+318.7% | Added | Holders |
| Q3 2021 | 17,023 | $50.0K | <0.1% | +17,023 | New | Holders |